Hu, Lulu http://orcid.org/0000-0001-7246-1736
Liu, Shun
Peng, Yong
Ge, Ruiqi
Su, Rui http://orcid.org/0000-0002-4807-6229
Senevirathne, Chamara
Harada, Bryan T. http://orcid.org/0000-0002-9683-782X
Dai, Qing http://orcid.org/0000-0002-8578-1568
Wei, Jiangbo http://orcid.org/0000-0003-2691-6490
Zhang, Lisheng
Hao, Ziyang
Luo, Liangzhi
Wang, Huanyu
Wang, Yuru
Luo, Minkui http://orcid.org/0000-0001-7409-7034
Chen, Mengjie http://orcid.org/0000-0003-1579-087X
Chen, Jianjun http://orcid.org/0000-0003-3749-2902
He, Chuan http://orcid.org/0000-0003-4319-7424
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG008935)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F32 CA221007, R01 CA214965, R01 CA236399, R01 CA211614)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01 GM126553)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK124116)
Article History
Received: 30 December 2020
Accepted: 28 January 2022
First Online: 14 March 2022
Change Date: 30 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41587-022-01616-4
Competing interests
: A patent application for m<sup>6</sup>A-SAC-seq has been filed by the University of Chicago. C.H. is a scientific founder and a scientific advisory board member of Accent Therapeutics, Inc., and Inferna Green, Inc. The remaining authors declare no competing interests.